ATOM - NASDAQ

Atomera Incorporated

ATOM·NASDAQ

$9.10

-7.6%

TechnologySemiconductors

Atomera Incorporated develops, commercializes, and licenses proprietary materials, processes, and technologies for the semiconductor industry in North America and the Asia Pacific. The company's lead technology is the Mears Silicon Technology, a thin film of reengineered silicon that can be applied as a transistor channel enhancement to CMOS-type transistors. Its customers include foundries, integrated device manufacturers, fabless semiconductor manufacturers, original equipment manufacturers, and electronic design automation companies. The company was formerly known as Mears Technologies, Inc. and changed its name to Atomera Incorporated in January 2016. Atomera Incorporated was incorporated in 2001 and is headquartered in Los Gatos, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$295.75M

EPS-0.6500

P/E Ratio-14.00

Earnings Date08/04/2026

21.09M

Assets

-28%

3Y-21.0%

5Y-46.0%

10Y-22.0%

2.71M

Total Liabilities

-33%

3Y-58.0%

5Y+32.0%

10Y+163.0%

18.38M

Total Equity

-27%

3Y-10.0%

5Y-51.0%

10Y-29.0%

Atomera Incorporated Funding & Solvency Profile

ATOM · NASDAQ

Current Assets

Cash & Cash Equivalents19.21M

Net Receivables54.00K

Inventory0.00

Other Current Assets338.00K

Total Current Assets20 M

Non-Current Assets

Property, Plant & Equipment1.48M

Goodwill & Intangible Assets0.00

Long-Term Investments0.00

Other Non-Current Assets14.00K

Total Non-Current Assets1 M

Total Assets

21.09M

Financial Health Analysis

Current Ratio

9.80x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.15x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

18 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

93% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Atomera Incorporated Balance Sheet

ATOM • NASDAQ

Atomera Incorporated Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	19.2M	25.8M	12.6M	21.2M	28.7M	37.9M	14.9M	18.9M	17.4M	26.7M	3.2M	21K	332.2K
Short-Term Investments	0.0	995K	6.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash & Short-Term Investments	19.2M	26.8M	19.5M	21.2M	28.7M	37.9M	14.9M	18.9M	17.4M	26.7M	3.2M	21K	332.2K
Net Receivables	54K	79K	629K	0.0	0.0	0.0	0.0	185K	110K	0.0	0.0	0.0	0.0
Accounts Receivables	0.0	6K	550K	0.0	0.0	0.0	0.0	185K	110K	0.0	0.0	0.0	0.0
Other Receivables	54K	73K	79K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Prepaids	0.0	0.0	0.0	0.0	309K	0.0	132K	170K	248K	96K	48K	24.1K	36K
Other Current Assets	338K	240K	244K	418K	0.0	132K	132K	170K	248K	96K	15K	15K	15K
Total Current Assets	19.6M	27.1M	20.4M	21.6M	29M	38.1M	15M	19.3M	17.7M	26.8M	3.3M	60.1K	383.2K
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	1.5M	1.9M	3.5M	5M	6.9M	858K	224K	56K	67K	28K	15.5K	21.2K	187.0
Other Non-Current Assets	14K	105K	105K	105K	105K	463K	13K	13K	13K	37K	144.7K	0.0	0.0
Total Non-Current Assets	1.5M	2M	3.6M	5.1M	7.1M	1.3M	237K	69K	80K	65K	160.2K	21.2K	187.0
Total Assets	21.1M	29.1M	24M	26.7M	36.1M	39.4M	15.2M	19.4M	17.8M	26.9M	3.4M	81.4K	383.4K
LIABILITIES
CURRENT LIABILITIES
Total Payables	608K	492K	618K	397K	338K	442K	315K	348K	198K	353K	301K	630.9K	139.7K
Accounts Payable	608K	492K	618K	397K	338K	442K	315K	348K	198K	353K	301K	630.9K	139.7K
Accrued Expenses	650K	1.6M	1.6M	1.1M	804K	705K	819K	1.2M	751K	678K	1.8M	143.8K	65K
Short Term Debt	567K	0.0	0.0	0.0	0.0	90K	152K	0.0	0.0	0.0	14.4M	0.0	3.7M
Capital Lease Obligations (Current)	0.0	1.5M	1.6M	1.4M	1.6M	0.0	152K	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	7K	4K	0.0	0.0	0.0	0.0	37K	55K	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	168K	0.0	0.0	0.0	0.0	211K	-14K	0.0	0.0	-678K	-204.0	0.0	0.0
Total Current Liabilities	2M	3.6M	3.8M	2.9M	2.8M	1.4M	1.5M	1.6M	949K	1M	16.5M	774.7K	3.9M
NON-CURRENT LIABILITIES
Long Term Debt	712K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6M	0.0
Other Non-Current Liabilities	-712K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Non-Current Liabilities	712K	471K	2M	3.5M	4.9M	602K	964K	1.2M	751K	678K	0.0	6.6M	0.0
Other Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	-964K	-1.2M	-751K	-678K	0.0	0.0	0.0
Capital Lease Obligations	712K	2M	3.6M	4.9M	6.5M	602K	152K	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	2.7M	4M	5.9M	6.4M	7.7M	2M	1.5M	1.6M	949K	1M	16.5M	7.4M	3.9M
SHAREHOLDERS' EQUITY
Common Stock	32K	31K	26K	24K	23K	22K	17K	15K	12K	12K	1.6K	1.2K	1.2K
Additional Paid-In Capital	260M	246.6M	221.2M	203.6M	194.2M	187.5M	149M	139.7M	125.9M	121.8M	70.5M	66.8M	66.7M
Retained Earnings	-241.7M	-221.5M	-203.1M	-183.3M	-165.9M	-150.1M	-135.3M	-122M	-109.1M	-96M	-83.4M	-73.9M	-70.1M
Accumulated Other Comprehensive Income/Loss	0.0	1K	0.0	0.0	0.0	0.0	0.0	-122K	-94K	-94K	-230.1K	-220.5K	-187.5K
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	377.0	0.0	0.0
Total Stockholders' Equity	18.4M	25.1M	18.2M	20.3M	28.4M	37.3M	13.8M	17.7M	16.9M	25.8M	-13.1M	-7.3M	-3.6M
Total Equity	18.4M	25.1M	18.2M	20.3M	28.4M	37.3M	13.8M	17.7M	16.9M	25.8M	-13.1M	-7.3M	-3.6M
SUMMARY
Total Liabilities & Equity	21.1M	29.1M	24M	26.7M	36.1M	39.4M	15.2M	19.4M	17.8M	26.9M	3.4M	81.4K	383.4K
Total Investments	0.0	995K	6.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Debt	2M	2M	3.6M	4.9M	6.5M	692K	152K	0.0	0.0	0.0	14.4M	6.6M	3.7M
Net Debt	-17.2M	-23.8M	-9M	-16.3M	-22.2M	-37.3M	-14.7M	-18.9M	-17.4M	-26.7M	11.2M	6.6M	3.4M
Shares Outstanding	31,482,800	31,482,800	31,482,800	31,482,800	31,482,800	31,482,800	31,482,800	31,482,800	31,482,800	31,482,800	31,482,800	31,482,800	31,482,800

SEC Filings

ATOM - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 13, 2026	May 12, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 05, 2026	March 31, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	March 27, 2026	May 12, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 24, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 24, 2026	February 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 23, 2026	February 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 12, 2026	February 12, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 11, 2026	February 05, 2026	2026	View Filing
10-Q 10-Q 2025 Q3 Q3	October 29, 2025	September 30, 2025	2025	View Filing

Showing 1 to 10 of 135 filings

Related Guides

Blog Categories

Continue your ATOM research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.